ロード中...
Global clinical response in Cushing’s syndrome patients treated with mifepristone
OBJECTIVE: Mifepristone, a glucocorticoid receptor antagonist, improves clinical status in patients with Cushing’s syndrome (CS). We examined the pattern, reliability and correlates of global clinical response (GCR) assessments during a 6-month clinical trial of mifepristone in CS. DESIGN: Post hoc...
保存先:
| 出版年: | Clin Endocrinol (Oxf) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BlackWell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255292/ https://ncbi.nlm.nih.gov/pubmed/24102404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.12332 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|